You have access
COX2/PTGS2 Expression Is Predictive of Response to Neoadjuvant Celecoxib in HER2-negative Breast Cancer Patients
PATRICIA DE CREMOUX, ANNE-SOPHIE HAMY, JACQUELINE LEHMANN-CHE, VÉRONIQUE SCOTT, BRIGITTE SIGAL, MARIE-CHRISTINE MATHIEU, PHILIPPE BERTHEAU, JEAN MARC GUINEBRETIÈRE, JEAN YVES PIERGA, SYLVIE GIACCHETTI, ETIENNE BRAIN, MICHEL MARTY, BERNARD ASSELAIN, FRÉDÉRIQUE SPYRATOS and IVAN BIÈCHE
Anticancer Research March 2018, 38 (3) 1485-1490;